Abstract
Despite the understanding of the importance of mitogen-activated protein (MAP) kinase activation in the stimulation of growth, little is known about the role of MAP kinase regulation during contact inhibited growth control. To investigate the role of the MAP kinase extracellular signal-regulated kinase (ERK) during the transition to a contact inhibited state, cultures of normal fibroblasts (BJ) were grown to different stages of confluency. The levels of MAP kinase phosphatase (MKP) expression and the amount of active ERK and MAP ERK kinase (MEK) in these cultures were assessed through western blot analysis and were compared to fibrosarcoma cell cultures (HT-1080), which lack contact inhibition. In normal fibroblasts, the amounts of active MEK and ERK decline at contact inhibition, concurrently with a rise in MKP-1, MKP-2, and MKP-3 protein levels. In contrast, fibrosarcoma cells appear to lack density-dependent regulation of the ERK pathway. Additionally, altering the redox environment of fibrosarcoma cells to a less reducing state, as seen during contact inhibition, results in increased MKP-1 expression. Taken together, these results suggest that the altered redox environment upon contact inhibition may contribute to the regulation of ERK inactivation by MKPs.
References
Holley RW: Control of growth of mammalian cells in culture. Nature 258: 487–490, 1975
Wieser RJ, Hack R, Oesch F: Involvement of plasma membrane glycoproteinsin the contact-dependent inhibition of growth of human fibroblasts. Exp Cell Res 158: 493–499, 1995
Gradl G, Faust D, Oesch F, Wieser RJ: Density-dependent regulation of cell growth by contactinhibin and the contactinhibin receptor. Current Biol 5: 536–535, 1995
Robinson MJ, Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180–186, 1997
Pelech SL: Networking with protein kinases. Curr Biol 3: 513–515, 1993
Kolch W: Meaningful relationships: the regulation of the Ras/Raf/ MEK/ERK pathway by protein interactions. Biochem J 351: 289–305, 2000
Pelech SL, Charest DL: MAP kinase-dependent pathways in cell cycle control. Prog Cell Cycle Res.1: 33–52, 1995
Ono K, Han J: The p38 signal transduction pathway: activation and function. Cell Signal 12: 1–13, 2000
Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Cell Biol 12: 186–192, 2000
Zhang ZY, Zhou B, Xie L: Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharm Therapeutics 93: 307–317, 2002
Liu Y, Gorospe M, Yang C,Holbrook NJ: Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress: inhibition of c-Jun N-terminal kinase activity and AP-1 dependent gene activation. J Biol Chem 270: 8377–8380, 1995
Tanoue T, Nishida E: Molecular recognitions in MAP kinase cascades. Cellular Signalling 15 455–462, 2003
Hutter DE, Till BG, Greene JJ: Redox state changes in density-dependent regulation of proliferation. Exp Cell Res 232: 435–438, 1997
Monteiro HP, Stern A: Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic Biol Med 21: 323–333, 1996
Hutter D, Greene JJ: Influence of the cellular redox state on NF-KB-regulated gene expression. J Cell Physiol 183: 45–52, 2000
Pouyssegur J, Volmat V, Lenormand P: Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Biochem Pharmacol 64: 755–763, 2002
Maestroni A, Tentori F, Meregalli G, Gabellini D, Asnaghi V, Ruggierri D, Zerbini G: Inhibition of MAP kinase cascade normalizes the proliferation of fibroblasts from patients with type 1 diabetes and nephropathy. J Diabetes Complications 19: 291–296, 2005
Yoshii M, Jikuhara A, Mori S, Iwagaki H, Takahashi HK, Nishibori M, Tanaka N: Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin-and MAP kinase-dependent manners. J Pharmacol Sci 98: 450–458, 2005
Wu Z, Wu LJ, Tashiro S, Onodera S, Ikejima T: Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression on shikonin-induced HeLa cell apoptosis. Chin Med J (Engl) 118: 671–677, 2005
Elder DL, Halton DE, Playle LC, Paraskeva C: The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Int J Cancer 99: 323–327, 2002
Theodosiou A, Ashworth A: MAP kinase phosphatases. Genome Biol 3: 1–10, 2002
Schafer FQ, Buettner GR: Redox environment of the cell as viewed through the redox stateof the glutathione disulfide/glutathione couple. Free Rad Biol Med 30: 1191–1212, 2001
Griffith OW: Mechanism of action, metabolism, and toxicity of buthionine sulfoximine andits higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 257: 13704–13712, 1982
Roovers K, Assoian RK: Integrating the MAP kinase signal into the G1 cell cycle phase machinery. Bioessays 22: 818–826, 2000
Polk DB, McCollum GW, Carpenter G: Cell density-dependent regulation of PLC gamma 1tyrosine phosphorylation and catalytic activity in an intestinal cell line (IEC-6) J Cell Physiol 162: 427–433, 1995
Bedrin MS, Abolafia CM, Thompson JF: Cytoskeletal association of epidermal growth factorreceptor and associated signaling proteins is regulated by cell density in IEC-6 intestinal cells. J Cell Physiol 172: 126–136, 1997
Vinals F, Pouyssegur J: Confluence of vascular endothelial cells induces cell cycle exitby inhibiting p42/p44 mitogen-activated protein kinase activity. Mol Cell Biol 19: 2763–2772, 1999
Li S, Gerrard ER, Balkovetz DF: Evidence for ERK1/2 phosophorylation controlling contact inhibition of proliferation in Madin-Darby Canine Kidney Epithelial cells. Am J Physiol 287: C432–439, 2004
Calipel A, Lefevre G, Pouponnot C, Mouriaux F, Eychene A, Mascarelli F: Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J Biol Chem 278: 42409–42418, 2003
Gysin S, Lee SH, Dean NM, McMahon M: Pharmacologic inhibition of RAF, MEK, ERK signalingelicits pancreatic cancer cell arrest through induced expression of p27Kip1. Cancer Res 65: 4870–4880, 2005
Sun H, Tonks NK, Bar-Sagi D: Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 266: 285–288, 1994
Brondello JM, McKenzie FR, Sun H, Tonks NK, Pouyssegur J: Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10: 1895–1904, 1995
Haddad JJ, Harb HL: L-γ-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)? Mol Immunol 42: 987–1014, 2005
Attene-Ramos K, Kitiphongspattana K, Ishii-Schrade K, Gaskins HR: Density-dependent changes in intracellular redox status in IEC-6 cells. 44th Annual Meeting, The American Society for Cell Biology, 2004
Kamata H, Hirata H: Redox regulation of cellular signaling. Cell Signal 11: 1–14, 1999
Fischer EH, Charbonneau H, Tonks NK: Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253: 401–406, 1991
Kabe Y, Ando K, Hirao S, Yoshida M, Handa H: Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395–403, 2005
Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE: Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93: 12908–23913, 1996
Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP: Activation of the mitogen-activatedprotein kinase signaling pathway in neutrophils: role of oxidants. J Biol Chem 269: 31234–31242, 1994
Wang X, Martindale JL, Liu Y, Holbrook NJ: The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333: 291–300, 1998
Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ: Activation of mitogen-activated protein kinases by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271: 4138–4142, 1996
Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185, 1995
Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV, Liu Y: The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem 279: 54023–54031, 2004
Lee YJ, Shukla SD: Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur J Pharmacol 508: 31–45, 2005
Tong Z, Singh G, Rainbow AJ: Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res 62: 5528–5535, 2002
Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL, Pescovitz OH: Mechanisms regulating the constitutive activation of the extracellular-signal regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 18: 2570–2582, 2004
Faust D, Dolado I, Cuadrado A, Oesch F, Weiss C, Nebreda AR, Dietrich C: p38alpha MAPK is required for contact inhibition. Oncogene [Epub ahead of print], 2005
Cazillis M, Bringuier AF, Delautier D, Buisiine M, Bernuau D, Gespach C, Groyer A: Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells. Oncogene 23: 4735–4744, 2004
McGinn S, Saad S, Poronnic P, Pollock C: High glucose mediated effects on endothelial cell proliferation occur via p38 MAP kinase. Am J Physiol Endocrinol Metab 285: E708–717, 2003
Lallemand D, Ham J, Garbay S, Bakiri L, Traincard F, Jeannequin O, Pfarr CM, Yaniv M: Stress-activated protein kinases are negatively regulated by cell density. EMBO J 17: 5615–5626, 1998
Suzuki E, Nagata D, Yoshizumi M, Kakoki M, Goto A, Omata M, Hirata Y: Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor. J Biol Chem 275: 3637–3644, 2000
Suzuki E, Nishimatsu H, Nagata D, Satonaka H, Goto A, Omata M, Fujita T, Nagai R, and Hirata, Y: Constitutive activation of proto-oncogene protein p21 induces cell cycle arrest in the G1 phase in contact-inhibited vascular endothelial cells. Hypertens Res 25: 773–778, 2002
Zhong Y, Lopez-Barcons L, Haigentz M, Ling YH, Perez-Soler R: Exogenous expression of H-cadherin in CHO cells regulates contact inhibition of cell growth by inducing p21 expression. Int J Oncol 24: 1573–1579, 2004
Batt DB, Roberts TM: Cell density modulates protein-tyrosine phosphorylation. J Biol Chem 273: 3408–3414, 1998
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wayne, J., Sielski, J., Rizvi, A. et al. ERK regulation upon contact inhibition in fibroblasts. Mol Cell Biochem 286, 181–189 (2006). https://doi.org/10.1007/s11010-005-9089-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9089-z